Nalaganje...
Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population‐based cohort study in Sweden and Norway
OBJECTIVE: To estimate survival in Swedish and Norwegian myelofibrosis (MF) patients who received ruxolitinib. METHODS: Swedish and Norwegian patients with MF diagnosis in the National Cancer Registries (Sweden: 2001‐2015; Norway: 2002‐2016) and ≥1 record of ruxolitinib in the Prescribed Drug Regist...
Shranjeno v:
| izdano v: | Eur J Haematol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899943/ https://ncbi.nlm.nih.gov/pubmed/31536656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13330 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|